Robert M. VanHimbergen - 01 Mar 2026 Form 4 Insider Report for Elanco Animal Health Inc (ELAN)

Reporting relationship: EVP and CFO
Issuer ticker: ELAN
Reported as of: 01 Mar 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 03 Mar 2026, 19:15:54 UTC
Prior SEC filing: 24 Feb 2026
Next SEC filing: 10 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Amy C. Seidel, as Attorney-in-Fact for Robert M. VanHimbergen

Key filing fact

Robert M. VanHimbergen filed Form 4 for Elanco Animal Health Inc (ELAN) on 03 Mar 2026.

Key facts

This page summarizes Robert M. VanHimbergen's Form 4 filing for Elanco Animal Health Inc (ELAN).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 03 Mar 2026, 19:15.

Change

Previous filing in this sequence was filed on 24 Feb 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001724169 Primary reporting owner

VanHimbergen Robert M

Relationship: EVP and CFO
Address: C/O ELANCO ANIMAL HEALTH INCORPORATED, 450 ELANCO CIRCLE, INDIANAPOLIS
Signature: /s/ Amy C. Seidel, as Attorney-in-Fact for Robert M. VanHimbergen
Signature date: 03 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ELAN transaction

Common Stock

Award

Transaction value: $0
Shares: +23,675
Change %: +19%
Price: $0.000000
Shares after: 148,652
Date: 01 Mar 2026
Ownership: Direct
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ELAN transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value: $0
Shares: +48,375
Change %
Price: $0.000000
Shares after: 48,375
Date: 01 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 48,375
Exercise price: $26.40
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Grant of restricted stock units vesting as follows: one-third vesting on March 1, 2027, one-third vesting on March 1, 2028, and the remaining vesting on March 1, 2029.

Footnote F2

Includes 744 shares acquired under Elanco Animal Health Inc.'s Employee Stock Purchase Plan on January 31, 2026.

Footnote F3

Grant of stock options vesting as follows: one-third vesting on March 1, 2027, one-third vesting on March 1, 2028, and the remaining vesting on March 1, 2029.